{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:28:44Z","timestamp":1788618524118,"version":"build-2803163510"},"reference-count":50,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T00:00:00Z","timestamp":1682208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Migraine is a prevalent disease associated with high levels of disability and is often underdiagnosed and undertreated. This systematic literature review aimed to identify the types of pharmacological and non-pharmacological strategies that community-dwelling adults report using to manage migraine. A systematic literature review of relevant databases, grey literature, websites, and journals was conducted from 1 January 1989 to 21 December 2021. Study selection, data extraction, and risk of bias assessment were completed independently by multiple reviewers. Data were extracted on migraine management strategies and categorized as opioid and non-opioid medications and medical, physical, psychological, or self-initiated strategies. A total of 20 studies were included. The sample sizes ranged from 138 to 46,941, with a mean age of 34.7 to 79.9 years. The data were typically collected using self-administered questionnaires (nine studies), interviews (five studies), online surveys (three studies), paper-based surveys (two studies), and a retrospective database (one study). Community-dwelling adults with migraine reported they primarily used medications, specifically triptans (range 9\u201373%) and non-steroidal anti-inflammatory drugs (NSAIDs) (range 13\u201385%) to manage migraine. Except for medical strategies, the use of other non-pharmacological strategies was low. Common non-pharmacological strategies included consulting physicians (range 14\u201379%) and heat or cold therapy (35%).<\/jats:p>","DOI":"10.3390\/clinpract13030051","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T06:20:42Z","timestamp":1682317242000},"page":"553-568","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of Pharmacological and Non-Pharmacological Strategies by Community-Dwelling Adults to Manage Migraine: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-2846","authenticated-orcid":false,"given":"Srujitha","family":"Marupuru","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, 1295 N. Martin Ave., Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad","family":"Almatruk","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, 1295 N. Martin Ave., Tucson, AZ 85721, USA"},{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, P.O. Box 80200, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion K.","family":"Slack","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, 1295 N. Martin Ave., Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-5996","authenticated-orcid":false,"given":"David R.","family":"Axon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, 1295 N. Martin Ave., Tucson, AZ 85721, USA"},{"name":"Center for Health Outcomes and PharmacoEconomic Research (HOPE Center), R. Ken Coit College of Pharmacy, The University of Arizona, 1295 N. Martin Ave., Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,23]]},"reference":[{"key":"ref_1","unstructured":"(2023, April 12). Chronic Pain. Available online: https:\/\/www.thelancet.com\/series\/chronic-pain."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1526-4610.2005.4501001.x","article-title":"Migraine: Epidemiology, impact, and risk factors for progression","volume":"45","author":"Lipton","year":"2005","journal-title":"Headache"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 629\u2013808.","DOI":"10.1177\/0333102417738202"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.2021.21857","article-title":"What is migraine?","volume":"327","author":"Walter","year":"2022","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","article-title":"Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Stovner","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1468-2982.2007.01401.x","article-title":"Patterns of triptans use: A study based on the records of a community pharmaceutical department","volume":"27","author":"Pavone","year":"2007","journal-title":"Cephalalgia"},{"key":"ref_9","unstructured":"(2023, April 12). A 10-Year Report Card Shows Migraine Remains Underdiagnosed and Undertreated. Available online: https:\/\/headaches.org\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/head.13752","article-title":"Workforce gap analysis in the field of headache medicine in the United States","volume":"60","author":"Burch","year":"2020","journal-title":"Headache"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11916-015-0500-5","article-title":"Well-established and empirically supported behavioral treatments for migraine","volume":"19","author":"Penzien","year":"2015","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_12","unstructured":"(2023, April 12). American Migraine Study I. Available online: https:\/\/headaches.org\/."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/sjpain-2018-0306","article-title":"Use of multidomain management strategies by community dwelling adults with chronic pain: Evidence from a systematic review","volume":"19","author":"Axon","year":"2019","journal-title":"Scand J. Pain"},{"key":"ref_14","first-page":"105","article-title":"Migraine headaches: Implications for management from a nationwide patient survey","volume":"11","author":"Adelman","year":"2000","journal-title":"Headache Q. Curr. Treat. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10072-014-1733-5","article-title":"Migraine attacks in the pharmacy: A survey in Piedmont, Italy","volume":"35","author":"Brusa","year":"2014","journal-title":"Neurol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Brusa, P., Allais, G., Scarinzi, C., Baratta, F., Parente, M., Rolando, S., Gnavi, R., Spadea, T., Costa, G., and Benedetto, C. (2019). Self-Medication for Migraine: A Nationwide Cross-Sectional Study in Italy. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0211191"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1097\/jnr.0000000000000429","article-title":"The frequency and perceived effectiveness of pain self-management strategies used by individuals with migraine","volume":"29","author":"Chang","year":"2021","journal-title":"J. Nurs. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1017\/S0317167100010738","article-title":"Migraine prevalence, treatment and impact: The Canadian women and migraine study","volume":"37","author":"Cooke","year":"2010","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1526-4610.2009.01395.x","article-title":"Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA Survey","volume":"49","author":"Donnet","year":"2009","journal-title":"Headache"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1526-4610.2010.01660.x","article-title":"Migraine and migraines of specialists: Perceptions and management","volume":"50","author":"Donnet","year":"2010","journal-title":"Headache"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1526-4610.2011.01939.x","article-title":"Use of antimigraine treatments by general practitioners","volume":"51","author":"Ducros","year":"2011","journal-title":"Headache"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0317167100047697","article-title":"Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: A Canadian population survey","volume":"20","author":"Edmeads","year":"1993","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000499910","article-title":"The association between chronicity of migraine and complementary and alternative medication use: The Turkish perspective","volume":"81","author":"Ertem","year":"2019","journal-title":"Eur. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/03007995.2021.1971179","article-title":"Comprehensive population-based survey of migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care of MigrainE (OVERCOME [Japan]) study","volume":"37","author":"Hirata","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"119337","DOI":"10.1016\/j.jns.2021.119337","article-title":"Use of traditional medicine in treatment of migraine during coronavirus disease 2019 (COVID-19) pandemic-an online survey","volume":"429","author":"Ismail","year":"2021","journal-title":"J. Neurolo. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1468-2982.2005.01077.x","article-title":"Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada","volume":"26","author":"Jelinski","year":"2006","journal-title":"Cephalalgia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1526-4610.2011.02029.x","article-title":"Examining the interrelationship of migraine onset, duration, and time to treatment","volume":"52","author":"Landy","year":"2012","journal-title":"Headache"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0333102416642603","article-title":"The quality of diagnosis and management of migraine and tension-type headache in three social groups in Russia","volume":"37","author":"Lebedeva","year":"2017","journal-title":"Cephalalgia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/head.13407","article-title":"Migraine in America Symptoms and Treatment (MAST) study: Baseline study methods, treatment patterns, and gender differences","volume":"58","author":"Lipton","year":"2018","journal-title":"Headache"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1526-4610.2006.00430.x","article-title":"Recognition and therapeutic management of migraine in 2004, in France: Results of FRAMIG 3, a French nationwide population-based survey","volume":"46","author":"Lucas","year":"2006","journal-title":"Headache"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1526-4610.2005.05111.x","article-title":"Patients\u2019 management of migraine and chronic daily headache: A study of the members of the migraine action association (United Kingdom)","volume":"45","author":"Peters","year":"2005","journal-title":"Headache"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4081\/ni.2018.7510","article-title":"Migraine: Incorrect self-management for a disabling disease","volume":"10","author":"Viticchi","year":"2018","journal-title":"Neurol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10194-010-0200-9","article-title":"Treatment of migraine and tension-type headache in Croatia","volume":"11","author":"Plavec","year":"2010","journal-title":"J. Headache Pain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/head.14053","article-title":"Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and effectiveness in migrAINe patients using preventive treatment (ATTAIN) study","volume":"61","author":"Kawata","year":"2021","journal-title":"Headache"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s40064-016-2211-8","article-title":"Recent advances in migraine therapy","volume":"5","author":"Antonaci","year":"2016","journal-title":"Springerplus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1526-4610.2011.01917.x","article-title":"Complementary and alternative medicine use among adults with migraines\/severe headaches","volume":"51","author":"Wells","year":"2011","journal-title":"Headache"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11940-010-0102-9","article-title":"Nonpharmacologic treatments for migraine and tension-type headache: How to choose and when to use","volume":"13","author":"Nicholson","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_39","first-page":"1","article-title":"Evidence-based guidelines for migraine headache: Behavioral and physical treatments","volume":"1","author":"Campbell","year":"2000","journal-title":"US Headache Consort."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ncl.2009.01.002","article-title":"Migraine in women","volume":"27","author":"Lay","year":"2009","journal-title":"Neurol. Clin."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1468-2982.2009.01909.x","article-title":"The use of migraine preventive medications among patients with and without migraine headaches","volume":"30","author":"Lafata","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10072-014-1732-6","article-title":"Prevention, education and information: The role of the community pharmacist in the management of headaches","volume":"35","author":"Giaccone","year":"2014","journal-title":"Neurol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1468-1331.2012.03681.x","article-title":"Self-medication of regular headache: A community pharmacy-based survey","volume":"19","author":"Mehuys","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_44","unstructured":"(2023, April 12). Dietary Supplements: Report Adverse Events to FDA. What Is an Adverse Event?, Available online: www.safetyreporting.hhs.gov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10900-013-9811-9","article-title":"Intentional misuse of over-the-counter medications, mental health, and polysubstance use in young adults","volume":"39","author":"Benotsch","year":"2014","journal-title":"J. Community Health"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5603\/PJNNS.a2022.0049","article-title":"COVID-19-related headache and innate immune response\u2014A narrative review","volume":"57","year":"2023","journal-title":"Neurol. Neurochi. Pol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jiph.2021.04.013","article-title":"The unusual course of a migraine attack during COVID-19 infection\u2014Case studies of three patients","volume":"14","author":"Budrewicz","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s10194-022-01400-4","article-title":"Headache onset after vaccination against SARS-CoV-2: A systematic literature review and meta-analysis","volume":"23","author":"Castaldo","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-143-6-200509200-00007","article-title":"Meta-analysis: Chronic disease self-management programs for older adults","volume":"143","author":"Chodosh","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.pec.2017.05.035","article-title":"Dis-integration of communication in healthcare education: Workplace learning challenges and opportunities","volume":"100","author":"Rosenbaum","year":"2017","journal-title":"Patient Educ. Couns."}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/13\/3\/51\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:21:36Z","timestamp":1760124096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/13\/3\/51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,23]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["clinpract13030051"],"URL":"https:\/\/doi.org\/10.3390\/clinpract13030051","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,23]]}}}